Tissue-type plasminogen activator (t-PA) plays an important role in the removal of intravascular fibrin deposits and has several physio-logical roles and pathological activities in the brain. Its production by many other cell types suggests that t-PA has additional functions out-side the vascular and central nervous system. Activity of t-PA is regu-lated at the level of its gene transcription, its mRNA stability and translation, its storage and regulated release, its interaction with co-factors that enhance its activity, its inhibition by inhibitors such as plasminogen activator inhibitor type 1 or neuroserpin, and its removal by clearance receptors. Gene transcription of t-PA is modulated by a large number of hormones, growth factors, cyto...
Fulltext embargoed for: 12 months post date of publicationPURPOSE: Tissue plasminogen activator (t...
Elucidating the pathogenic mechanisms of Alzheimer's disease (AD) to identify therapeutic targets ha...
Plasminogen activator inhibitor 1 (PAI-1) is a glycoprotein that controls the activity of the key en...
Tissue-type plasminogen activator (t-PA ) plays an important role in the removal of intravascular fi...
T HE PLASMINOGEN activator (PA) system is responsi- ble for the degradation of intravascular blood c...
For over a decade, tissue-type plasminogen activator (t-PA), a serine protease classically known for...
The expression of the tissue plasminogen activator (t-PA) gene appears to be under epige-netic contr...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
doi: 10.3389/fncel.2015.00456 The serine protease tissue-type plasminogen activator (tPA) is used as...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
T he application of molecular biology to medical practice has led to the mass production of otherwis...
Plasminogen activators have been implicated in physiological events including fibrinolysis and tissu...
Elucidating the pathogenic mechanisms of Alzheimer’s disease (AD) to identify therapeutic targets ha...
Elucidating the pathogenic mechanisms of Alzheimer's disease (AD) to identify therapeutic targets ha...
Elucidating the pathogenic mechanisms of Alzheimer’s disease (AD) to identify therapeutic targets ha...
Fulltext embargoed for: 12 months post date of publicationPURPOSE: Tissue plasminogen activator (t...
Elucidating the pathogenic mechanisms of Alzheimer's disease (AD) to identify therapeutic targets ha...
Plasminogen activator inhibitor 1 (PAI-1) is a glycoprotein that controls the activity of the key en...
Tissue-type plasminogen activator (t-PA ) plays an important role in the removal of intravascular fi...
T HE PLASMINOGEN activator (PA) system is responsi- ble for the degradation of intravascular blood c...
For over a decade, tissue-type plasminogen activator (t-PA), a serine protease classically known for...
The expression of the tissue plasminogen activator (t-PA) gene appears to be under epige-netic contr...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
doi: 10.3389/fncel.2015.00456 The serine protease tissue-type plasminogen activator (tPA) is used as...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
T he application of molecular biology to medical practice has led to the mass production of otherwis...
Plasminogen activators have been implicated in physiological events including fibrinolysis and tissu...
Elucidating the pathogenic mechanisms of Alzheimer’s disease (AD) to identify therapeutic targets ha...
Elucidating the pathogenic mechanisms of Alzheimer's disease (AD) to identify therapeutic targets ha...
Elucidating the pathogenic mechanisms of Alzheimer’s disease (AD) to identify therapeutic targets ha...
Fulltext embargoed for: 12 months post date of publicationPURPOSE: Tissue plasminogen activator (t...
Elucidating the pathogenic mechanisms of Alzheimer's disease (AD) to identify therapeutic targets ha...
Plasminogen activator inhibitor 1 (PAI-1) is a glycoprotein that controls the activity of the key en...